Clinical Trials Results Reporting: Update from London
From London, Applied Clinical Trial's Editor-in-Chief Lisa Henderson provides an update on CBI's Inaugural Clinical Trial Registries and Results Databases conference.
While a record-breaking snowfall in London made travel difficult for speakers and attendees alike, the "show went on" for the Center for Business Intelligence's Inaugural Clinical Trial Registries and Results Databases conference held for the first time outside the United States.
The attendees-largely of course from Europe-came to learn more about the international registry requirements for clinical trials, as well as the newly-implemented clinical trials results requirements on clinicaltrials.gov. FDAAA's requirement called for the trial results implementation at the end of September 2008. We last reported on the topic in October. See,
As was evident, pharma and government alike are struggling with these new transparency initiatives. While no one is against transparency in clinical trials, a number of issues regarding data, analysis, various stakeholders, ethics and more came to light during the conference. Nicholas Ide, chief architect of ClinicalTrials.gov said updated the attendees on the challenges they have had regarding information and data submitted to clinicaltrials.gov results. Of 250-plus results submitted, approximately 46 have been published to the Web site. The others? Sent back to sponsors with comments and questions. A spring meeting has not yet been formally scheduled to update the next steps in the clinicaltrials.gov clinical trials results reporting database.
Kevin Palmaccio, conference producer, noted that conference went very well, despite the weather challenges. "We made a lot of accomplishments here and a lot of good discussion with various stakeholders. More still needs to be done, but there is good momentum."
Editor's Note: A news article from this conference will appear in March. Also, CBI is an Advanstar Communications company, which is also the parent company of Applied Clinical Trials.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025